INS and obesity disorder: This mutation has been shown to be associated with obesity [10], hyperinsulinaemia [10], decreased glucose tolerance [7], [11], increased insulin sensitivity [7], [11], hyper-lipidaemia, and decreased plasma free fatty acids [7].